Atossa Therapeutics Seeks Clinical Investigation Approval from FDA to Launch the COVID-19 HOPE Study
SEATTLE, April 20, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), has applied to the FDA for approval to […]
TOP Ships Inc. Announces Conclusion of Sale of M/T Palm Springs
ATHENS, Greece, April 20, 2020 (GLOBE NEWSWIRE) — TOP Ships Inc. (the “Company”), an international owner and operator of modern, […]
Genetic Technologies Announces $1.44 Million Registered Direct Offering
MELBOURNE, Australia, April 20, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in […]
Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on […]
Kratos Awarded $2.7 Million Sole-Source Award for Drone Mission Command and Control Kits
SAN DIEGO, April 20, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions […]
Enphase Energy Upgrade Program Enables Contact-Free Solar Sales and Installations
FREMONT, Calif., April 20, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s […]
The Alkaline Water Company Increases Production Capacity Significantly to Meet Demand
SCOTTSDALE, Ariz., April 20, 2020 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER) (the “Company”), is a producer […]
NETSOL Technologies Provides Updates on COVID-19 Impact and Response
CALABASAS, Calif., April 20, 2020 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application […]
Cue Biopharma Announces Clinical Trial Collaboration Agreement with Merck to Evaluate CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment For HPV+ Recurrent/Metastatic Head and Neck Cancer
– Ongoing Phase 1 dose escalation and expansion study with CUE-101 as a monotherapy in post first-line recurrent/metastatic HNSCC patients […]
Encore Capital Group to Announce First Quarter 2020 Financial Results on May 11
SAN DIEGO, April 20, 2020 (GLOBE NEWSWIRE) — Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today […]
